Hyperliquid Strategies (NASDAQ:PURR) Shares Gap Up – Time to Buy?

Hyperliquid Strategies Inc (NASDAQ:PURR) gapped up prior to trading on Thursday. The stock had previously closed at $9.97, but opened at $11.28. Hyperliquid Strategies shares last traded at $10.9270, with a volume of 11,374,535 shares trading hands.

Hyperliquid Strategies News Summary

Here are the key news stories impacting Hyperliquid Strategies this week:

• Positive Sentiment: Wall Street giant Intercontinental Exchange and billionaire investor Stanley Druckenmiller were reported to be backing the Hyperliquid blockchain and its derivatives ecosystem. The developments strengthen the platform’s institutional credibility and helped drive interest in PURR and Hyperliquid’s HYPE token. Stock Market Today, Oct. 29: Hyperliquid Strategies Stock Surges 23% as Wall Street Giant and Billionaire Stanley Druckenmiller Back Hyperliquid
• Positive Sentiment: Druckenmiller publicly endorsed a Hyperliquid-related venture in his first post on X while disclosing an indirect investment of approximately $23 million in Trade[XYZ]. His involvement may improve visibility for Hyperliquid’s perpetual-futures market and attract additional investors. Stanley Druckenmiller’s first X post backs Hyperliquid venture after $23 million indirect investment
• Positive Sentiment: Exchange-traded products linked to Hyperliquid reportedly surged following the Druckenmiller-related disclosure, indicating heightened market demand for exposure to the ecosystem. Hyperliquid-linked ETFs Surge Amid Druckenmiller’s Trade XYZ Investment
• Neutral Sentiment: Trading activity was unusually bullish, with investors purchasing 48,921 PURR call options—about 56% above typical daily call volume. This signals speculative optimism but also highlights the stock’s elevated volatility.
• Negative Sentiment: After the news-driven rally, the stock’s subsequent pullback may reflect profit-taking and near-term volatility rather than a deterioration in the company’s underlying Hyperliquid strategy.

Wall Street Analyst Weigh In

A number of analysts have commented on the company. Weiss Ratings lowered Hyperliquid Strategies from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, October 23rd. Wall Street Zen lowered Hyperliquid Strategies from a “hold” rating to a “sell” rating in a report on Sunday, October 11th. Compass Point initiated coverage on Hyperliquid Strategies in a report on Monday, September 14th. They issued a “buy” rating and a $18.00 target price on the stock. Chardan Capital lifted their target price on Hyperliquid Strategies from $9.75 to $17.00 and gave the company a “buy” rating in a research report on Friday, August 28th. Finally, Cantor Fitzgerald upped their price target on Hyperliquid Strategies from $22.60 to $34.20 and gave the stock an “overweight” rating in a report on Thursday, September 10th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Buy” and a consensus price target of $19.80.

Hyperliquid Strategies Stock Down 10.4%

The company has a market capitalization of $3.06 billion, a PE ratio of -1.71 and a beta of 1.89. The stock has a 50-day moving average of $11.43 and a 200 day moving average of $7.99.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. BlackRock Inc. purchased a new position in Hyperliquid Strategies in the second quarter valued at approximately $79,842,000. Paradigm Operations LP purchased a new position in shares of Hyperliquid Strategies during the 2nd quarter valued at $44,936,535. OLP CAPITAL MANAGEMENT Ltd purchased a new position in shares of Hyperliquid Strategies during the 1st quarter valued at $10,459,000. Wealth High Governance Capital Ltda bought a new position in shares of Hyperliquid Strategies during the 2nd quarter worth $6,517,000. Finally, Tidal Investments LLC bought a new position in shares of Hyperliquid Strategies during the 2nd quarter worth $5,285,000. Institutional investors own 9.45% of the company’s stock.

Hyperliquid Strategies Company Profile

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.